Cardlytics, Inc. (CDLX)

NASDAQ:
CDLX
| Latest update: Feb 23, 2026, 7:25 PM

Stock events for Cardlytics, Inc. (CDLX)

Cardlytics reported Q2 2025 earnings, missing revenue estimates despite a user increase. The company repaid convertible notes, focusing on liquidity. CDLX was listed among pre-market active stocks. Cardlytics announced a workforce reduction. The company reported Q3 2025 results, outperforming EPS estimates but missing revenue forecasts, while achieving positive adjusted EBITDA and reduced expenses. Zacks upgraded Cardlytics to a 'Buy' rating. David Evans was appointed as CFO. Zacks again upgraded Cardlytics to a 'Buy'. Cardlytics announced an inducement grant. CDLX's stock price has declined significantly over the past year and has underperformed the US Media industry and the broader US Market. Insider trading activity has been characterized by selling from executives.

Demand Seasonality affecting Cardlytics, Inc.’s stock price

Cardlytics' business experiences demand seasonality, with Q1 2025 results indicating a seasonally weak quarter.

Overview of Cardlytics, Inc.’s business

Cardlytics, Inc. is a commerce media platform that uses first-party purchase data to enhance commerce for consumers, advertisers, and publishers. It operates in the media and advertising sector, focusing on performance marketing and loyalty programs. Cardlytics partners with financial institutions to integrate its advertising platform into their digital banking channels. The Cardlytics platform enables marketers to reach customers with personalized offers through digital channels, driving sales. The Bridg platform utilizes point-of-sale data for analytics, targeted loyalty marketing, and campaign impact measurement, also offering identity resolution capabilities.

CDLX’s Geographic footprint

Cardlytics operates in the United States and the United Kingdom. The company has visibility into approximately half of all card-based transactions in the U.S. and a quarter in the U.K. It serves over 4,000 financial institutions in the United States, reaching approximately 150 million U.S. consumers.

CDLX Corporate Image Assessment

Cardlytics aims to make commerce smarter and more rewarding by providing personalized cash-back offers within a privacy-safe environment. The company focuses on democratizing advertising and fostering loyalty. While there were no specific events impacting brand reputation, the company's focus on privacy and value contributes to its professional standing. The workforce reduction in October 2025 could have had an internal and external perception impact.

Ownership

Cardlytics' ownership is a mix of institutional, retail, and individual investors. Institutional investors own approximately 11.08% of the stock, with CAS Investment Partners, LLC being the largest single holder. Insiders own about 11.52% of the stock. Public companies and individual investors hold approximately 77.41% of the company's stock, with Clifford Sosin owning the most shares among individual investors.

Expert AI

Show me the sentiment for Cardlytics, Inc.
What's the latest sentiment for Cardlytics, Inc.?

Price Chart

$0.87

4.63%
(1 month)

Top Shareholders

CAS Investment Partners LLC
9.62%
The Vanguard Group, Inc.
4.83%
Bank of America Corp.
2.70%
683 Capital Management LLC
2.59%
KPS Global Asset Management UK Ltd.
2.25%
Worldly Partners Management LLC
2.14%
BlackRock, Inc.
1.79%
RBF Capital LLC
1.48%

Trade Ideas for CDLX

Today

Sentiment for CDLX

News
Social

Buzz Talk for CDLX

Today

Social Media

FAQ

What is the current stock price of Cardlytics, Inc.?

As of the latest update, Cardlytics, Inc.'s stock is trading at $0.87 per share.

What’s happening with Cardlytics, Inc. stock today?

Today, Cardlytics, Inc. stock is down by -4.63%, possibly due to news.

What is the market sentiment around Cardlytics, Inc. stock?

Current sentiment around Cardlytics, Inc. stock is negative, based on recent news, trading volume, and analyst opinions.

Is Cardlytics, Inc.'s stock price growing?

Over the past month, Cardlytics, Inc.'s stock price has decreased by -4.63%.

How can I buy Cardlytics, Inc. stock?

You can buy Cardlytics, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol CDLX

Who are the major shareholders of Cardlytics, Inc. stock?

Major shareholders of Cardlytics, Inc. include institutions such as CAS Investment Partners LLC (9.62%), The Vanguard Group, Inc. (4.83%), Bank of America Corp. (2.70%) ... , according to the latest filings.